The next stage of chronic care management and value-based insurance design for the continuing onslaught of high-priced specialty drugs, including PCSK9 inhibitors.
Patrick Dunham
Advertisement
Articles by Patrick Dunham
Advertisement
Latest Updated Articles
- Top ways to tap value from specialty drugs for chronic care
Published: September 9th 2015 | Updated:
Advertisement
Advertisement
